TRAF4调节了无处不在调节的幸存者周转率,并赋予了放射电阻
Jinzhuang Liao1,2, Xiang Qing3, Xiaoying Li1,2
1Department of Radiology, The Third Xiangya Hospital of Central South University, Changsha, 410013, Hunan, China.
International journal of biological sciences
|January 2, 2024
概括
瘤亡因子受体相关因子4 (TRAF4) 在鼻癌 (NPC) 中过度表达,并驱动放射电阻. 准TRAF4可能会增加NPC治疗中的放射性敏感性.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- 放射治疗后鼻癌 (NPC) 复发需要确定耐药性因素.
- 瘤亡因子受体相关因子4 (TRAF4) 是一个潜在的治疗点.
研究的目的:
- 调查TRAF4在NPC辐射敏感性中的作用.
- 阐明TRAF4介导的放射电阻背后的分子机制.
主要方法:
- 在NPC细胞和组织中分析TRAF4表达.
- 在体外和体内进行TRAF4敲击实验.
- 对Akt/Wee1/CDK1/幸存者轴的西部斑点分析.
主要成果:
- 在NPC中,TRAF4过度表达,与p-Akt和生存相关.
- 通过抑制Akt/Wee1/CDK1轴,TRAF4的淘汰增强了NPC的放射性敏感性.
- 抑制TRAF4抑制了幸存者的酸化,并促进了其降解.
- 在试验室和异种移植模型中,TRAF4的敲击战胜了放射电阻.
结论:
- 对于NPC的放射电阻,TRAF4生存轴至关重要.
- 针对TRAF4是一个有前途的战略,用于NPC治疗中的放射敏感化.
相关概念视频
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Adaptive Mechanisms in Cancer Cells
5.8K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.8K
DNA Damage can Stall the Cell Cycle
9.2K
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.2K
Receptor Downregulation in MVBs
2.1K
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
2.1K
DNA Damage Can Stall the Cell Cycle
2.6K
2.6K


